NEXO
12.3.2024 17:26:34 CET | Business Wire | Press release
20+ leading crypto organizations including BTC Inc, Bitget, Brink, Chainalysis, Hacken, Nansen, and Unstoppable Domains have come together for the 'Bitcoin Deserves an Emoji' movement, initiated by Nexo. Uniting the global crypto community, the initiative aims to introduce a Bitcoin emoji to any digital keyboard and emphasize cryptocurrency's triple identity as money, technology, and culture in today’s society.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312299831/en/
Uniting the global crypto community, the 'Bitcoin Deserves an Emoji' initiative aims to introduce a Bitcoin emoji to any digital keyboard and emphasize cryptocurrency's triple identity as money, technology, and culture in today’s society. (Graphic: Business Wire)
This community-driven initiative starts with a 50-day petition on Change.org, followed by an official proposal to the Unicode Consortium during the 2024 submission window. The new, widespread effort for a Bitcoin emoji, once turned down in 2020, shows just how important blockchain has become in our daily lives.
Celebrating Community, Culture, and Collective Values
92% of internet users worldwide use emojis in their digital communications, according to Unicode. Originating in Japan in the 1990s, emojis have transformed from niche pictographs to key elements of online conversations, transcending language and borders to reflect our values, innovations, and contemporary culture. Similarly, Bitcoin, beyond being a mere asset, displays the technological breakthrough of blockchain, embodying principles of decentralization, transparency, and security. Its inclusion as an emoji would not only symbolize its indispensable role in today's digital and financial landscapes but also ensure Bitcoin is recognized as an integral part of daily life across the globe.
Voices of the Movement
Already gaining substantial traction, the Bitcoin Emoji Initiative showcases the unity within the cryptocurrency community and the shared goal of further establishing Bitcoin's presence in our cultural landscape.
“Bitcoin's journey reflects a remarkable blend of innovation and community. It's time its significance is recognized universally, starting with a symbol we all understand - an emoji. Join us in making history,” said Kosta Kantchev, Co-founder & Executive Chairman of Nexo.
“Bitcoin is universal money for the world, it needs a universal emoji for every person, young and old to use,” said David Bailey, CEO of BTC Inc.
“Supporting Bitcoin's development has always been about changing the world through code. An official emoji is a nod to Bitcoin's technological impact on the world.” said Mike Schmidt, Executive Director of Brink.
"Bitget recognizes the significance of having a Bitcoin emoji as a universal symbol of digital assets in our everyday communication. This initiative aligns with our mission to promote crypto adoption and accessibility. We wholeheartedly support this endeavor and believe it will contribute further to mainstream acceptance of the whole industry. Together with our partners and the wider crypto community, we are committed to advocating for the inclusion of a Bitcoin emoji on keyboards worldwide,” said Gracy Chen, Managing Director of Bitget.
"We fully support Nexo's petition as this initiative to create a Bitcoin Emoji aligns perfectly with Nansen's commitment to fostering a more inclusive and expressive crypto environment”, said Alex Svanevik, CEO and co-founder of Nansen.
“For a decade, Chainalysis has been dedicated to fostering trust in blockchains while aiding the advancement of the web3 ecosystem and assisting public sector entities in staying abreast of crypto developments. As a trailblazer in blockchain analysis, we've safeguarded and championed Bitcoin since its inception. We commend Nexo's advocacy for acknowledging a cultural symbol—the Bitcoin emoji—a testament to the era we inhabit”, said Ian Andrews, CMO of Chainalysis.
"The definition of an emoji is a small digital image or icon used to express an idea. Bitcoin is now a well-known idea across all countries. CryptoQuant fully supports Nexo's initiative to facilitate the global mass adoption of Bitcoin," said CryptoQuant's CEO Ki Young Ju.
“The Bitcoin emoji reflects the essence of decentralization, representing a collective movement towards a more open and inclusive financial future for everyone. We align with Nexo's Bitcoin Emoji petition,” said Sam Lekhak, Head of Marketing & Comms at Liquity.
“We're thrilled to stand alongside industry leaders in championing a Bitcoin emoji, a move poised to give identity to the industry while also serving as a bridge between technical innovation and cultural expression,” said Sandy Carter, COO, Unstoppable Domains
Join the Movement
Everyone is invited to be part of this historic community-driven initiative. By signing the Change.org petition and advocating for the Bitcoin emoji, everyone can contribute to celebrating Bitcoin's legacy and future. For more information and to join the campaign, visit bitcoinemoji.org.
About the Initiative
This initiative is a collaborative effort by 20+ leading organizations in the cryptocurrency space, united by a common goal to promote understanding, adoption, and technological progress of digital currencies. Participating organizations: Nexo, Brink, Bitget, Chainalysis, Polygon, Brave, BTC Inc, Hacken, CryptoQuant, Nansen, Unstoppable Domains, Liquity, Mara, Busha, Zulu, Cadenza, Bware Labs, Meta4 Capital, Sift, MarketAcross, Bitcompare, Bithomp, Milkroad, Crypto Oasis.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240312299831/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom